Product NDC: | 65841-768 |
Proprietary Name: | Zolmitriptan |
Non Proprietary Name: | Zolmitriptan |
Active Ingredient(s): | 5 mg/1 & nbsp; Zolmitriptan |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65841-768 |
Labeler Name: | Cadila Healthcare Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202890 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130516 |
Package NDC: | 65841-768-01 |
Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65841-768-01) |
NDC Code | 65841-768-01 |
Proprietary Name | Zolmitriptan |
Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65841-768-01) |
Product NDC | 65841-768 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Zolmitriptan |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20130516 |
Marketing Category Name | ANDA |
Labeler Name | Cadila Healthcare Limited |
Substance Name | ZOLMITRIPTAN |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |